| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement of Reviewers
|
|
|
2015
|
4 |
6 |
p. A3-A4
nvt p.
|
artikel
|
| 2 |
A placebo controlled trial for an NMO relapse prevention treatment: Ethical considerations
|
Rhodes, Rosamond
|
|
2015
|
4 |
6 |
p. 580-584
5 p.
|
artikel
|
| 3 |
A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS)
|
O’Connell, K.
|
|
2015
|
4 |
6 |
p. 521-525
5 p.
|
artikel
|
| 4 |
Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder
|
Mutch, Kerry
|
|
2015
|
4 |
6 |
p. 614-618
5 p.
|
artikel
|
| 5 |
Disability status and dental pathology in multiple sclerosis patients
|
Dulamea, Adriana Octaviana
|
|
2015
|
4 |
6 |
p. 567-571
5 p.
|
artikel
|
| 6 |
Editors' Welcome
|
Banwell, Brenda
|
|
2015
|
4 |
6 |
p. A1-A2
nvt p.
|
artikel
|
| 7 |
Eye and hand motor interactions with the Symbol Digit Modalities Test in early multiple sclerosis
|
Nygaard, Gro O.
|
|
2015
|
4 |
6 |
p. 585-589
5 p.
|
artikel
|
| 8 |
Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database
|
Capkun, Gorana
|
|
2015
|
4 |
6 |
p. 546-554
9 p.
|
artikel
|
| 9 |
Multimodal neurophysiological evaluation of primary progressive multiple sclerosis – An increasingly valid biomarker, with limits
|
Canham, L.J.W.
|
|
2015
|
4 |
6 |
p. 607-613
7 p.
|
artikel
|
| 10 |
Natalizumab-induced hepatic injury: A case report and review of literature
|
Antezana, A
|
|
2015
|
4 |
6 |
p. 495-498
4 p.
|
artikel
|
| 11 |
Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach
|
Ota, Miho
|
|
2015
|
4 |
6 |
p. 515-520
6 p.
|
artikel
|
| 12 |
Neuro-oncology dilemma: Tumour or tumefactive demyelinating lesion
|
Abdoli, Mohammad
|
|
2015
|
4 |
6 |
p. 555-566
12 p.
|
artikel
|
| 13 |
Novel composite MRI scale correlates highly with disability in multiple sclerosis patients
|
Kosa, Peter
|
|
2015
|
4 |
6 |
p. 526-535
10 p.
|
artikel
|
| 14 |
Patient-reported outcomes in multiple sclerosis: Relationships among existing scales and the development of a brief measure
|
Chua, Alicia S.
|
|
2015
|
4 |
6 |
p. 598-606
9 p.
|
artikel
|
| 15 |
Placebo controlled trials in neuromyelitis optica are needed and ethical
|
Cree, Bruce A.C.
|
|
2015
|
4 |
6 |
p. 536-545
10 p.
|
artikel
|
| 16 |
Prevalence of multiple sclerosis in Brazil: A systematic review
|
da Gama Pereira, Ana Beatriz Calmon Nogueira
|
|
2015
|
4 |
6 |
p. 572-579
8 p.
|
artikel
|
| 17 |
Primary spinal oligoastrocytoma mimicking longitudinally extensive transverse myelitis
|
Yeo, T.R.
|
|
2015
|
4 |
6 |
p. 590-593
4 p.
|
artikel
|
| 18 |
Relationship between gait initiation and disability in individuals affected by multiple sclerosis
|
Galli, Manuela
|
|
2015
|
4 |
6 |
p. 594-597
4 p.
|
artikel
|
| 19 |
Season of birth and multiple sclerosis in Tunisia
|
Sidhom, Youssef
|
|
2015
|
4 |
6 |
p. 491-494
4 p.
|
artikel
|
| 20 |
The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ 9 -tetrahydrocannabinol acting through CB1 receptors
|
Moreno-Martet, Miguel
|
|
2015
|
4 |
6 |
p. 505-511
7 p.
|
artikel
|
| 21 |
The ethics of placebo controlled clinical trials in NMO – A balance of risks
|
Levy, Michael
|
|
2015
|
4 |
6 |
p. 512-514
3 p.
|
artikel
|
| 22 |
The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life
|
Sandi, Dániel
|
|
2015
|
4 |
6 |
p. 499-504
6 p.
|
artikel
|
Tijdschrift beschrijving